News

The patient succumbed to the deadly virus at a private hospital in Perinthalmanna. His test results returned Nipah positive ...
Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases ...
Recent double-blind, randomized, controlled trials reported that human umbilical cord-derived mesenchymal stem cell (MSC) infusions in COVID-19 patients with acute respiratory distress syndrome ...
The global sepsis diagnostics market size was US$ 570 million in 2021. The global sepsis diagnostics market size is forecast to reach US$ 1,111.26 million by 2030, growing at a compound annual growth ...
Three De-suup trainees, a man and two women, have died at the national referral hospital after a Leptospirosis outbreak at a ...
Surveillance and medical protocols are in place, but environmental factors for the epidemic reappearing regularly cannot be ruled out.
Bonus Biogroup (TASE: BONS), a late-stage biotechnology company priming immunomodulatory and regenerative mesenchymal stem cells (MSC) to develop novel tissue engineering and cell therapy solutions, ...
Kerala, which first reported Nipah outbreak in 2018, has recorded four cases this year so far, of which two have died, one recovered and the other is undergoing treatment.
Measurements The primary outcome measure was a composite endpoint of the incidence of acute respiratory distress syndrome, postoperative pulmonary ... of surgery or hospital discharge if earlier (3) ...
Cardiovascular diseases are a major global health concern, causing millions of deaths annually. Recognizing early warning signs like chest pain, short ...
Objective To determine the incidence of acute respiratory illness (ARill) in athletes and by method of diagnosis, anatomical classification, ages, levels of performance and seasons. Design Systematic ...